[go: up one dir, main page]

DE602004009030D1 - Phenyltetrazol-Verbindungen - Google Patents

Phenyltetrazol-Verbindungen

Info

Publication number
DE602004009030D1
DE602004009030D1 DE602004009030T DE602004009030T DE602004009030D1 DE 602004009030 D1 DE602004009030 D1 DE 602004009030D1 DE 602004009030 T DE602004009030 T DE 602004009030T DE 602004009030 T DE602004009030 T DE 602004009030T DE 602004009030 D1 DE602004009030 D1 DE 602004009030D1
Authority
DE
Germany
Prior art keywords
phenyltetrazole
connections
angiotensin
antagonists
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004009030T
Other languages
English (en)
Other versions
DE602004009030T2 (de
Inventor
Gabriele Razzetti
Domenico Magrone
Mauro Ercoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dipharma Francis SRL
Original Assignee
Dipharma Francis SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipharma Francis SRL filed Critical Dipharma Francis SRL
Publication of DE602004009030D1 publication Critical patent/DE602004009030D1/de
Application granted granted Critical
Publication of DE602004009030T2 publication Critical patent/DE602004009030T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE602004009030T 2003-11-28 2004-11-19 Phenyltetrazolverbindungen Expired - Lifetime DE602004009030T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002338A ITMI20032338A1 (it) 2003-11-28 2003-11-28 Composti feniltetrazolici.
ITMI20032338 2003-11-28

Publications (2)

Publication Number Publication Date
DE602004009030D1 true DE602004009030D1 (de) 2007-10-31
DE602004009030T2 DE602004009030T2 (de) 2008-06-12

Family

ID=34611237

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004009030T Expired - Lifetime DE602004009030T2 (de) 2003-11-28 2004-11-19 Phenyltetrazolverbindungen

Country Status (9)

Country Link
US (2) US7345072B2 (de)
EP (1) EP1555260B1 (de)
JP (1) JP2005162751A (de)
AT (1) ATE373645T1 (de)
DE (1) DE602004009030T2 (de)
ES (1) ES2273617T3 (de)
IT (1) ITMI20032338A1 (de)
PL (1) PL1555260T3 (de)
PT (1) PT1555260E (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1706401A1 (de) 2004-09-02 2006-10-04 Teva Pharmaceutical Industries Ltd. Herstellung von olmesartan-medoxomil
DE102004060699A1 (de) * 2004-12-16 2006-06-22 Ratiopharm Gmbh Verfahren zur Herstellung von Candesartan
WO2006067216A2 (en) * 2004-12-22 2006-06-29 Enantia, S. L. Intermediate compounds for the preparation of an angiotensin ii receptor and process for the preparation of valsartan
JP2007526342A (ja) 2005-01-03 2007-09-13 テバ ファーマシューティカル インダストリーズ リミティド 低レベルの不純物を有するオルメサルタンメドキソミル
WO2007005967A2 (en) * 2005-07-05 2007-01-11 Teva Pharmaceutical Industries Ltd. Process for preparing valsartan
EP1816131A1 (de) * 2006-02-06 2007-08-08 KRKA, tovarna zdravil, d.d., Novo mesto Verfahren zur Herstellung von Olmesartan Medoxomil
CA2616466A1 (en) * 2005-07-29 2007-02-15 Krka Process for the preparation of olmesartan medoxomil
WO2007071750A1 (en) * 2005-12-22 2007-06-28 Enantia, S.L. Intermediates and processes for the preparation of valsartan
ES2300175B1 (es) * 2006-02-14 2009-06-08 Inke, S.A. Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo.
ITMI20061848A1 (it) * 2006-09-27 2008-03-28 Dipharma Spa Procedimento per la preparazione di composti feniltetrazolici
BRPI0815111A2 (pt) * 2007-08-08 2015-01-27 Lek Pharmaceuticals Processo para a preparação ou purificação de olmesartan medoxomil, sais de olmesartan medoxomil e seus usos e composições farmacêuticas
EP2432777A1 (de) 2009-05-20 2012-03-28 Ranbaxy Laboratories Limited Verfahren zur herstellung von olmesartan-medoxomil
KR101117128B1 (ko) * 2009-06-02 2012-03-14 한국화학연구원 페닐테트라졸 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 골다공증 또는 비만의 예방 또는 치료용 약학적 조성물
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof
CN102675294A (zh) * 2012-05-17 2012-09-19 浙江天宇药业股份有限公司 一种合成氯沙坦及其中间体的方法
CN105001209A (zh) * 2015-06-29 2015-10-28 千辉药业（安徽）有限责任公司 一种厄贝沙坦的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5412102A (en) * 1994-05-27 1995-05-02 Syntex (U.S.A.) Inc. Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid
TW409125B (en) * 1996-04-22 2000-10-21 Novartis Ag Antivirally active heterocyclic azahexane derivatives
ATE314097T1 (de) * 1996-10-28 2006-01-15 Amersham Health As Kontrastmittel
JP2002145770A (ja) * 2000-08-30 2002-05-22 Sankyo Co Ltd 心不全の予防又は治療のための医薬組成物

Also Published As

Publication number Publication date
EP1555260B1 (de) 2007-09-19
ES2273617T3 (es) 2008-03-16
ITMI20032338A1 (it) 2005-05-29
ES2273617T1 (es) 2007-05-16
PL1555260T3 (pl) 2008-02-29
EP1555260A1 (de) 2005-07-20
US20080119657A1 (en) 2008-05-22
ATE373645T1 (de) 2007-10-15
US20050119488A1 (en) 2005-06-02
PT1555260E (pt) 2007-12-04
DE602004009030T2 (de) 2008-06-12
US7345072B2 (en) 2008-03-18
JP2005162751A (ja) 2005-06-23

Similar Documents

Publication Publication Date Title
DE602004009030D1 (de) Phenyltetrazol-Verbindungen
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
ATE543807T1 (de) Verstärker von glutamat-rezeptoren
CL2013002895A1 (es) Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005).
DE502005009089D1 (de) 1-methyl-3-trifluormethyl-pyrazol-4-carbonsäure-(ortho-phenyl)-anilide und ihre verwendung als fungizid
ATE451381T1 (de) Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
DE602005013819D1 (de) Pyridincarbonsäureamidderivate zur verwendung als antikrebsmittel
ATE419250T1 (de) 2-cyanopyrrolidincarbonsäureamide als dipeptidylpeptidase-iv-inhibitoren
EA200700192A1 (ru) Производные фталазина в качестве ингибиторов parp
DK1501507T3 (da) Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet
ATE481987T1 (de) Verfahren zur radiofluoridierung von biologisch aktiven vektoren
DE60214990D1 (de) Benzolsulfonsäureester-indol-5-yl als 5-ht6 rezeptor-antagonisten
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
ATE353878T1 (de) Pyridyloxyalkancarbonsäureamid-derivate verwendbar als fungizide
DE50305374D1 (de) Neue prodrugs von 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(n -2-pyridil-n-2-hydroxycarbonylethyl)-amid, ihre herstellung und ihre verwendung als arzneimittel
DE60326263D1 (de) Pyrimidin-sulfonamide und ihre verwendung als endothelin-rezeptor-antagonisten
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
ATE390427T1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
CO5540291A2 (es) Benzamidoacetonitrilos y su uso como antiparasitarios
DE502006003030D1 (de) Verwendung von inhibitoren des na+/h+ austauschers, subtyp 5 (nhe5) zur gedächtnisverbesserung
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe
ECSP056174A (es) Acidos hidroxamicos utiles en el tratamiento detrastornos hiperproliferativos
DE602004010530D1 (de) Verfahren zur herstellung von phenyltetrazolderivaten
DE602004009313D1 (de) Organosiliziumverbindungen und deren verwendung
ATE299491T1 (de) Benzoltricarbonsäureamide als aktivatoren des insulinrezeptors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition